Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome
NCT00003123
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Myelodysplastic Syndromes
Interventions
DRUG:
amifostine trihydrate
Sponsor
Providence Hospital